semaglutide approved UT San Antonio study: As FDA for weight management, calls to poison control centers skyrocketed in the U.S Novo Nordisk and Hims &

The medication is not recommended during pregnancy, in patients with severe gastrointestinal disease including severe gastroparesis, or in those with a history of pancreatitis

2 New developments in obesity pharmacotherapy: disease modifying properties Semaglutide and tirzepatide are indicated for treatment of diabetes and marketed for both diabetes and chronic weight management under different trade names

At Centra Internal Medicine, we are committed to providing our patients with the latest, evidence-based treatments for chronic conditions such as type 2 diabetes and obesity

It is well known that NF-B is the predominant regulator of inflammation and cGAS-STING can drive NF-B activity during viral infections ( 4.2 The cGAS-STING pathway interacts with the inflammasome complex in viral infections NLRs also have powerful effects on inflammation induction

The California BOP has not offered any scientific or safety-based explanation for why this widely used and celebrated treatment should be restricted

The Science Behind BPC-157 Wound Healing Understanding how BPC-157 promotes wound healing requires examining its effects on several interconnected biological pathways